Genmab reported DKK14M in Interest Income for its fiscal quarter ending in March of 2026.





Interest Income Change Date
Agios Pharmaceuticals USD 9.73M 1.06M Jun/2026
Almirall EUR 1.54M 1.18M Jun/2026
Amarin USD 3.37M 3.37M Dec/2024
argenx SE USD 45M 3M Sep/2026
AstraZeneca USD 80M 7M Jun/2026
Bayer EUR 169M 39M Dec/2025
BioMarin Pharmaceutical USD 4.63M 5.85M Sep/2026
Exelixis USD 14.32M 105K Sep/2026
Fresenius Medical Care EUR 16.05M 1.35M Sep/2026
Genmab DKK 14M 11M Mar/2026
GlaxoSmithKline GBP 58M 36M Jun/2026
GN Store Nord DKK 30M 9M Sep/2026
GRIFOLS EUR 9.56M 4.5M Jun/2025
Hikma Pharmaceutical USD 4M 0 Dec/2024
Insmed USD 765K 55K Sep/2024
Lakefront Biotherapeutics EUR 13.56M 991K Mar/2026
Merck EUR 25M 11M Jun/2026
Regeneron Pharmaceuticals USD 183.3M 200K Jun/2026
Sanofi EUR 77M 17M Jun/2026